Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Polymenidou, M; Prokop, S; Jung, H H; Hewer, E; Peretz, D; Moos, R; Tolnay, M; Aguzzi, A (2011). Atypical prion protein conformation in familial prion disease with PRNP P105T mutation. Brain Pathology, 21(2):209-214.

Baral, P K; Wieland, B; Swayampakula, M; Polymenidou, M; Aguzzi, A; Kav, N N V; James, M N G (2011). Crystallization and preliminary X-ray diffraction analysis of prion protein bound to the Fab fragment of the POM1 antibody. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications, 67(Pt 10):1211-1213.

Hafner-Bratkovic, I; Bester, R; Pristovsek, P; Gaedtke, L; Veranic, P; Gaspersic, J; Mancek-Keber, M; Avbelj, M; Polymenidou, M; Julius, C; Aguzzi, A; Vorberg, I; Jerala, R (2011). Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. Journal of Biological Chemistry, 286(14):12149-12156.

Kranich, J; Krautler, N J; Heinen, E; Polymenidou, M; Bridel, C; Schildknecht, A; Huber, C; Kosco-Vilbois, M H; Zinkernagel, R; Miele, G; Aguzzi, A (2008). Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. Journal of Experimental Medicine, 205(6):1293-1302.

Polymenidou, M; Trusheim, H; Stallmach, L; Moos, R; Julius, C; Miele, G; Lenz-Bauer, C; Aguzzi, A (2008). Canine MDCK cell lines are refractory to infection with human and mouse prions. Vaccine, 26(21):2601-2614.

Heikenwalder, M; Kurrer, M O; Margalith, I; Kranich, J; Zeller, N; Haybaeck, J; Polymenidou, M; Matter, M; Bremer, J; Jackson, W S; Lindquist, S; Sigurdson, C J; Aguzzi, A (2008). Lymphotoxin-dependent prion replication in inflammatory stromal cells of granulomas. Immunity, 29(6):998-1008.

Le Pichon, C E; Valley, M T; Polymenidou, M; Chesler, A T; Sagdullaev, B T; Aguzzi, A; Firestein, S (2008). Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nature Neuroscience, 12(1):60-69.

Polymenidou, M; Moos, R; Scott, M; Sigurdson, C; Shi, Y Z; Yajima, B; Hafner-Bratkovic, I; Jerala, R; Hornemann, S; Wuthrich, K; Bellon, A; Vey, M; Garen, G; James, M N G; Kav, N; Aguzzi, A (2008). The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS ONE, 3(12):e3872.

Aguzzi, A; Heikenwalder, M; Polymenidou, M (2007). Insights into prion strains and neurotoxicity. Nature Reviews. Molecular Cell Biology, 8(7):552-561.

Sigurdson, C J; Manco, G J; Schwarz, P; Liberski, P; Hoover, E A; Hornemann, S; Polymenidou, M; Miller, M W; Glatzel, M; Aguzzi, A (2006). Strain fidelity of chronic wasting disease upon murine adaptation. Journal of Virology, 80(24):12303-12311.

Polymenidou, M; Stoeck, K; Glatzel, M; Vey, M; Bellon, A; Aguzzi, A (2005). Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurology, 4(12):805-814.

Donofrio, G; Heppner, F L; Polymenidou, M; Musahl, C; Aguzzi, A (2005). Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. Journal of Virology, 79(13):8330-8338.

Sigurdson, C B; Polymenidou, M; Aguzzi, A (2005). Reconstructing prions: fibril assembly from simple yeast to complex mammals. Neurodegenerative Diseases, 2(1):1-5.

Polymenidou, M; Heppner, F L; Pellicioli, E C; Urich, E; Miele, G; Braun, N; Wopfner, F; Schätzl, H M; Becher, B; Aguzzi, A (2004). Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 101(S2):14670-14676.

Heikenwalder, M; Polymenidou, M; Junt, T; Sigurdson, C J; Wagner, H; Akira, S; Zinkernagel, R M; Aguzzi, A (2004). Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nature Medicine, 10(2):187-192.

Aguzzi, A; Polymenidou, M (2004). Mammalian prion biology: one century of evolving concepts. Cell, 116(2):313-327.

This list was generated on Tue Sep 19 18:45:59 2017 CEST.